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CASE REPORT
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Abstract
Cardiac troponins can be useful in monitoring cardiac injury following perinatal distress. We report here an increase of
cardiac troponin I (cTnI) to 2.84 mg/l at 3 weeks (age-related median: 0.07 mg/l) followed by normalization in a newborn
with an uneventful clinical course after resuscitation at birth. Serial echocardiographs showed normal cardiac function. Such
a time course of cTnI, not previously reported, could be due to either a greater sensitivity of biochemical markers than of
instrumental tools or birth asphyxia. Larger studies are needed.
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Introduction
Transient myocardial ischemia (TMI) and myocar-
dial damage are relatively common complications of
birth asphyxia and other perinatal conditions [1–3].
In the past, the diagnosis of neonatal cardiac injury
was difficult due to the lack of specific biochemical
markers. The recent availability of cardiac troponins
with higher tissue specificity than other markers such
as creatine kinase MB fraction [3–5] suggests their
adoption as reliable indicators of cardiac injury even
in newly born infants [6].
We report here the case of a newborn who
required resuscitation for a short time in the delivery
room and thereafter presented with an atypical and
prolonged rise of cardiac troponin I (cTnI) level.
Case report
A female infant was born at term by spontaneous
delivery (birth weight 2780 g). She showed mild birth
asphyxia (Apgar score: 1 min= 3, 5 min= 9) and
required bag and mask ventilation with oxygen. She
was therefore admitted to our neonatal intensive-care
unit (NICU) in good clinical condition. Balanced
mild metabolic acidosis (pH= 7.42, arterial pCO2=
24 mmHg, HCO3= 15.4 mmol/l, arterial lactate =
5 mmol/l) was demonstrated 90 min after birth. As
part of the standard care of asphyxiated newborn
infants, we performed continuous electrocardio-
graphic monitoring and serial measurements of
cTnI using an automated analyzer (Dimension RxL;
Dade Behring, Newark, DE, USA). The analytical
performance was similar to that described elsewhere
[7]: in particular, day-to-day coefficient of variation
was lower than 10%. No electrocardiographic sign of
TMI emerged in the first 48 h of life according to
Jedeikin’s criteria [1]. Echocardiography in the first
day of life excluded congenital heart diseases,
coronary anomalies and left ventricular segmental
dysfunction. The clinical and laboratory course was
uneventful. Thus, on day 2 of life, the infant was
transferred from the NICU to the normal care unit of
our institution even though cTnI concentration
showed an upward trend (Figure 1) during the first
days of life. The latter exceeded the upper reference
limit (Table I) we previously defined for our neonatal
population [8]. The patient was discharged on day 3
of life, in healthy condition and breastfed. Electro-
cardiograms, echocardiographic recordings and
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blood cTnI assays were therefore scheduled for
follow-up. In the following weeks the infant was
healthy and showed normal cardiac function (left
ventricular ejection fraction consistently remained
around 70%). However, cTnI concentration in-
creased markedly to a peak value of 2.84 mg/l at 3
weeks of life, returning within the reference interval at
3.5 months (0.12 mg/l) and falling to below 0.1 mg/l at
9.5 months of age (Figure 1).
Discussion
Troponins usually show near-zero background levels
in adults as well as newly born infants [5]. Thus, a
rise of troponin, even in the absence of echocardio-
graphic findings or other markers of elevation,
reliably indicates cardiac damage or myocardial
ischemia [9].
Interestingly, short-lived cTnI elevations have been
reported in adult patients with chest pain without
cardiac ischemic disease [10], and troponin level have
been evaluated for detecting minor myocardial
damage in adult patients with acute non-cardiac
disease [11]. Furthermore, in newborns, several
perinatal conditions can be complicated by TMI or
troponin elevations following a perinatal injury [1–
3,6,12]. Even if, according to many authors, TMI is a
self-limiting problem, the effects of a long-lasting
event, if any, have been considered a relevant question
since TMI was first reported [1].
In the present case report we describe an episode
of mild perinatal asphyxia followed by a healthy
clinical course associated with increased cTnI
extending until the 3rd week of life. The latter
course has been previously reported [3], but the
remarkable aspect of our case is that cTnI remained
high for a long time (almost until 3 months of life)
without any clinical or instrumental sign of cardio-
vascular disease (Figure 1). To our knowledge, this is
the first report of such a time course of cTnI in a
newborn and we speculate a role of birth asphyxia.
The intrinsic mechanism might be due to a
fragmentation of troponins and/or their intracellular
compartmentation [3,5]. Nevertheless, the phenom-
enon remains only partly understood.
Both the lack of any evidence of TMI in the
clinical course of our case and the lack of any
echocardiographic evidence of left ventricular seg-
mental dysfunction in the follow-up could suggest
that cTnI might provide higher sensitivity than
instrumental diagnostic tools at substantially lower
cost. Larger studies are needed to confirm this
potential.
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Figure 1. Plasma concentration of cardiac troponin I (cTnI)
from day 1 to day 294 of life.
Table I. Upper reference limits for plasma concentration (mg/l) of
cardiac troponin I in the first month of life.





1 34 0.07 0.04 0.15
2 17 0.11 0.04 0.15
3 12 0.11 0.03 0.18
8–12 16 0.14 0.05 0.26
13–21 10 0.07 0.02 0.1
22–30 11 0.16 0.08 0.32
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